Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is There Now An Opportunity In Abiomed (ABMD) Stock?

Touchstone Sands Capital Institutional Growth Fund recently released its Q1 2020 Investor Letter, a copy of which you can download below. The fund posted a return of -9.45% for the quarter, outperforming its benchmark, the Russell 1000 Growth Index which returned -14.10% in the same quarter. You should check out Touchstone Sands Capital’s top 5 stock picks for investors to buy right now, which could be the biggest winners of the stock market crash. There weren’t a lot of funds who could deliver these kinds of returns without shorting the market or using aggressive put options.

In the said letter, Touchstone Sands Capital highlighted a few stocks and Abiomed Inc (NASDAQ:ABMD) is one of them. Abiomed is a manufacturer of medical implant devices. Year-to-date, ABMD stock gained 8.2% and on May 14th it had a closing price of $184.27. Its market cap is of $8.3 billion. Here is what Touchstone Sands Capital said:

“The Fund sold Abiomed in March to make room for a new business. We continue to have confidence that Abiomed’s Impella device can become more widely adopted over time for severe cardiac failure. However, with the recent setbacks, this will likely take longer than originally expected, and will be more reliant on new clinical data. Given the market dislocations caused by the coronavirus outbreak, we believe the business’s opportunity cost is too high. We always viewed Abiomed as an emerging franchise with a wide cone of outcomes, and managed this risk in the Fund through a small portfolio weight.”

In Q4 2019, the number of bullish hedge fund positions on ABMD stock increased by about 46% from the previous quarter (see the chart here).

Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.